About Contact Us Careers
Sign In

CAR T-Cell Therapy Market - Top Companies and Manufacturers

  • Report ID: 2441
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Companies Dominating the CAR T-Cell Therapy Landscape

    • Novartis International AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Gilead Sciences, Inc.
    • Pfizer Inc.
    • Johnson & Johnson
    • Amgen Inc.
    • Bellicum Pharmaceuticals, Inc.
    • Immune Therapeutics
    • Sorrento Therapeutics
    • Celgene Corporation
    • Bluebird Bio
Browse Key Market Insights with Data Illustration:

In the News


Author Credits:  Radhika Pawar


  • Report ID: 2441
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing research resulting in development of effective targeted therapies such as CAR T-cell therapy and growing cases of cancer are factors driving the market growth.

The market is anticipated to attain a CAGR of 35% over the forecast period, i.e. 2020-2028.

North America is anticipated to provide more business opportunities for growth on account of growing FDA approvals of therapies in the United States.

The major players in the market are Novartis International AG, Gilead Sciences, Inc., Pfizer Inc., Johnson & Johnson, Amgen Inc., Bellicum Pharmaceuticals, Inc., Immune Therapeutics, Sorrento Therapeutics, Celgene Corporation and Bluebird Bio.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample